- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x ARG- TYR- GLY- PHE- VAL- ALA- ASN- PHE: PB1 peptide(Non-covalent)
- 33 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 9 residues within 4Å:- Chain A: G.208, A.237, D.239, T.241, F.242, Q.243
- Chain B: R.13, H.14
- Ligands: EDO.20
Ligand excluded by PLIPEDO.3: 4 residues within 4Å:- Chain A: I.24, D.38
- Chain B: D.54, L.55
Ligand excluded by PLIPEDO.4: 5 residues within 4Å:- Chain A: R.132, E.149, H.152, A.154, E.155
Ligand excluded by PLIPEDO.5: 2 residues within 4Å:- Chain A: D.221, E.223
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: R.45, M.46, E.47, W.61
Ligand excluded by PLIPEDO.7: 4 residues within 4Å:- Chain A: Y.85, M.139, A.140, I.143
Ligand excluded by PLIPEDO.8: 3 residues within 4Å:- Chain A: S.89, E.90
- Ligands: EDO.15
Ligand excluded by PLIPEDO.9: 6 residues within 4Å:- Chain A: R.15, E.20, P.21, S.39, D.40, R.76
Ligand excluded by PLIPEDO.10: 1 residues within 4Å:- Chain A: I.143
Ligand excluded by PLIPEDO.11: 3 residues within 4Å:- Chain A: E.56, R.171, N.175
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain A: D.31, G.240, F.242
- Ligands: EDO.36, EDO.37
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain A: A.159, Y.160, T.164
Ligand excluded by PLIPEDO.14: 3 residues within 4Å:- Chain A: A.150, A.151, H.152
Ligand excluded by PLIPEDO.15: 4 residues within 4Å:- Chain A: N.87, Q.88, S.89
- Ligands: EDO.8
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain A: T.32, A.50, P.51, W.52, T.179, L.180
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain A: Q.219, H.261, T.272
- Ligands: TRS.27
Ligand excluded by PLIPEDO.18: 7 residues within 4Å:- Chain A: R.7, F.9, Y.28, D.30, D.31
- Chain B: Y.64
- Ligands: EDO.37
Ligand excluded by PLIPEDO.19: 6 residues within 4Å:- Chain A: E.213, I.214, T.215, Q.263, H.264, E.265
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain A: K.187, L.207, G.208
- Ligands: EDO.2
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain A: H.189, T.191, W.205, L.207
- Ligands: EDO.29
Ligand excluded by PLIPEDO.22: 3 residues within 4Å:- Chain A: L.273, R.274, E.276
Ligand excluded by PLIPEDO.23: 5 residues within 4Å:- Chain A: F.110, E.129, L.131, R.158, E.162
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain A: Y.86, Y.119, K.122
Ligand excluded by PLIPEDO.29: 9 residues within 4Å:- Chain A: L.207, R.235, Q.243
- Chain B: Y.11, S.12, H.14, P.15, M.100
- Ligands: EDO.21
Ligand excluded by PLIPEDO.30: 7 residues within 4Å:- Chain B: Q.9, V.10, V.94, K.95, W.96, D.97, M.100
Ligand excluded by PLIPEDO.31: 4 residues within 4Å:- Chain B: S.58, K.59, D.60, S.62
Ligand excluded by PLIPEDO.32: 5 residues within 4Å:- Chain A: R.22, I.24
- Chain B: S.34, D.35, L.55
Ligand excluded by PLIPEDO.33: 2 residues within 4Å:- Chain B: E.51, H.52
Ligand excluded by PLIPEDO.34: 8 residues within 4Å:- Chain B: L.41, K.42, N.43, G.44, E.78, Y.79, A.80, K.95
Ligand excluded by PLIPEDO.35: 7 residues within 4Å:- Chain A: F.9, M.99, Q.116
- Chain B: F.57, S.58, K.59, W.61
Ligand excluded by PLIPEDO.36: 5 residues within 4Å:- Chain A: P.236
- Chain B: S.53, Y.64
- Ligands: EDO.12, EDO.37
Ligand excluded by PLIPEDO.37: 7 residues within 4Å:- Chain A: Y.28, D.31, F.242
- Chain B: Y.64
- Ligands: EDO.12, EDO.18, EDO.36
Ligand excluded by PLIPEDO.38: 4 residues within 4Å:- Chain A: G.238
- Chain B: R.13, F.23, Y.68
Ligand excluded by PLIP- 2 x ZN: ZINC ION(Non-covalent)
- 2 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
TRS.27: 5 residues within 4Å:- Chain A: Q.219, G.222, E.223, D.224
- Ligands: EDO.17
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:E.223, A:E.223, A:D.224, A:D.224
- Water bridges: A:Q.219, A:Q.219
TRS.39: 6 residues within 4Å:- Chain B: D.35, I.36, E.37, N.84, H.85, V.86
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:E.37, B:E.37, B:N.84
- Water bridges: B:D.35, B:V.86
- 1 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Asa, M. et al., Crystal structures of N-myristoylated lipopeptide-bound HLA class I complexes indicate reorganization of B-pocket architecture upon ligand binding. J.Biol.Chem. (2022)
- Release Date
- 2022-06-22
- Peptides
- MHC class I antigen: A
Beta-2-microglobulin: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x ARG- TYR- GLY- PHE- VAL- ALA- ASN- PHE: PB1 peptide(Non-covalent)
- 33 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 1 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Asa, M. et al., Crystal structures of N-myristoylated lipopeptide-bound HLA class I complexes indicate reorganization of B-pocket architecture upon ligand binding. J.Biol.Chem. (2022)
- Release Date
- 2022-06-22
- Peptides
- MHC class I antigen: A
Beta-2-microglobulin: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B